Hepatitis B Virus Vaccine(HBV)

Developed for: hepatitis B virus infection
Investigated by: Eunice Dube · National University of Science and Technology, Zimbabwe

today NCT06786429 · Ph 4

20272028202920302031

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT06786429	Aug 2026 → Sep 2031 expected	cervical cancer, gallstones, hepatitis B virus infection, human papilloma virus infection +2	Eunice Dube	Not yet recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Hepatitis B Virus Vaccine(HBV)	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06786429 ↗
Modality	Vaccine	“Biological: Hepatitis B Virus Vaccine(HBV)” NCT06786429 ↗